DBV Technologies
http://dbpedia.org/resource/DBV_Technologies an entity of type: Thing
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.
rdf:langString
DBV Technologies est une entreprise française, créée en 2002 qui développe des solutions de diagnostic et de traitement des allergies alimentaires, arachide et lait de vache. Elle est cotée à la bourse de Paris.
rdf:langString
rdf:langString
DBV Technologies
rdf:langString
DBV Technologies
rdf:langString
DBV Technologies SA
rdf:langString
DBV Technologies SA
xsd:integer
38460994
xsd:integer
1123864815
rdf:langString
Bagneux, France
rdf:langString
rdf:langString
Bertrand Dupont
rdf:langString
Christophe Dupont
rdf:langString
rdf:langString
Kevin Trapp
rdf:langString
Daniel Tasse
rdf:langString
Ramzi Benamar
rdf:langString
DBV Technologies logo.svg
xsd:integer
100
rdf:langString
Allergy treatments, Allergy diagnosis
rdf:langString
DBV Technologies
rdf:langString
NASDAQ:DBVT
rdf:langString
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.
rdf:langString
DBV Technologies est une entreprise française, créée en 2002 qui développe des solutions de diagnostic et de traitement des allergies alimentaires, arachide et lait de vache. Elle est cotée à la bourse de Paris.
xsd:nonNegativeInteger
11746
xsd:gYear
2002